Prevalence of aPL in healthy asymptomatic individuals is 1–5% for anti-CL and 3% for anti-β2GPI.38 The predictive value for APS clinical events in asymptomatic carriers has been addressed by few studies. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.